[{"id":"3c4991de-db64-4065-98be-20d6b4e3f446","acronym":"","url":"https://clinicaltrials.gov/study/NCT03848676","created_at":"2021-01-18T18:59:48.511Z","updated_at":"2024-07-02T16:35:36.215Z","phase":"","brief_title":"Genomic and Phenotypic Determinants of Resistance to Immunotherapies in Multiple Myeloma","source_id_and_acronym":"NCT03848676","lead_sponsor":"University of Turin, Italy","biomarkers":" CD8 • IL6 • CD38 • CRBN • DKK1 • CD4 • CD55 • CD59","pipe":" | ","alterations":" CD38 expression • CRBN mutation","tags":["CD8 • IL6 • CD38 • CRBN • DKK1 • CD4 • CD55 • CD59"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD38 expression • CRBN mutation"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 40","initiation":"Initiation: 07/01/2018","start_date":" 07/01/2018","primary_txt":" Primary completion: 06/01/2024","primary_completion_date":" 06/01/2024","study_txt":" Completion: 07/01/2024","study_completion_date":" 07/01/2024","last_update_posted":"2023-09-21"},{"id":"4aa9cd03-5fde-4391-b4ff-8540a03d4fc2","acronym":"","url":"https://clinicaltrials.gov/study/NCT01642121","created_at":"2021-01-18T07:04:04.804Z","updated_at":"2024-07-02T16:37:31.985Z","phase":"","brief_title":"Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia","source_id_and_acronym":"NCT01642121","lead_sponsor":"Children's Oncology Group","biomarkers":" CD38 • CD34 • CD55","pipe":"","alterations":" ","tags":["CD38 • CD34 • CD55"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 08/01/2012","start_date":" 08/01/2012","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":"","study_completion_date":"","last_update_posted":"2016-05-19"}]